Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jake Whang

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Chest|July 11, 2021
ResponseNakwon Kwak, Jake Whang, Jae-Joon Yim
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 15, 2026
Adjunctive and supportive strategies to mitigate drug toxicities in the treatment of nontuberculous mycobacterial disease with future directionsHo Won Kim, Hoe Sun Yoon, Jake Whang, et al.
Journal of Infection and Public Health|March 20, 2021
Tuberculosis: A persistent unpleasant neighbour of humansMitsuko Seki, Hongjo Choi, Kyungjong Kim, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|December 30, 2011
Disseminated infection due to Mycobacterium avium subsp. avium in an Asian elephant (Elephas maximus)Hwanyul Yong, Go-Eun Choi, Byung Soo Lee, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2022
Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis InfectionLee-Han Kim, Soon Myung Kang, Jake Whang, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|August 10, 2024
Pan-lineage Mycobacterium tuberculosis reference genome for enhanced molecular diagnosisKunhyung Bahk, Joohon Sung, Mitsuko Seki, et al.
Chest|July 27, 2020
Minimal Inhibitory Concentration of Clofazimine Among Clinical Isolates of Nontuberculous Mycobacteria and Its Impact on Treatment OutcomeNakwon Kwak, Jake Whang, Jeong Seong Yang, et al.
Tuberculosis and Respiratory Diseases|December 9, 2025
Trends and Sociodemographic Characteristics of Nontuberculous Mycobacterial Infections in South Korea: A Nationwide NHIS-Based Study (2010-2022)Jeong Mi Seo, Sungchan Kang, Taeyoon Lim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2024
Relationship Between Clarithromycin Minimum Inhibitory Concentrations and Treatment Responses in Mycobacterium avium Complex Pulmonary DiseaseJoong-Yub Kim, Hyeontaek Hwang, DaHae Yim, et al.
Annals of the American Thoracic Society|January 29, 2024
The Impact of Trehalose Dimycolate on the Clinical Course of <i>Mycobacterium avium</i> Complex Pulmonary DiseaseJihoo Lee, Nagatoshi Fujiwara, Joong-Yub Kim, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Chest|July 11, 2021
ResponseNakwon Kwak, Jake Whang, Jae-Joon Yim
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 15, 2026
Adjunctive and supportive strategies to mitigate drug toxicities in the treatment of nontuberculous mycobacterial disease with future directionsHo Won Kim, Hoe Sun Yoon, Jake Whang, et al.
Journal of Infection and Public Health|March 20, 2021
Tuberculosis: A persistent unpleasant neighbour of humansMitsuko Seki, Hongjo Choi, Kyungjong Kim, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|December 30, 2011
Disseminated infection due to Mycobacterium avium subsp. avium in an Asian elephant (Elephas maximus)Hwanyul Yong, Go-Eun Choi, Byung Soo Lee, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2022
Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis InfectionLee-Han Kim, Soon Myung Kang, Jake Whang, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|August 10, 2024
Pan-lineage Mycobacterium tuberculosis reference genome for enhanced molecular diagnosisKunhyung Bahk, Joohon Sung, Mitsuko Seki, et al.
Chest|July 27, 2020
Minimal Inhibitory Concentration of Clofazimine Among Clinical Isolates of Nontuberculous Mycobacteria and Its Impact on Treatment OutcomeNakwon Kwak, Jake Whang, Jeong Seong Yang, et al.
Tuberculosis and Respiratory Diseases|December 9, 2025
Trends and Sociodemographic Characteristics of Nontuberculous Mycobacterial Infections in South Korea: A Nationwide NHIS-Based Study (2010-2022)Jeong Mi Seo, Sungchan Kang, Taeyoon Lim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2024
Relationship Between Clarithromycin Minimum Inhibitory Concentrations and Treatment Responses in Mycobacterium avium Complex Pulmonary DiseaseJoong-Yub Kim, Hyeontaek Hwang, DaHae Yim, et al.
Annals of the American Thoracic Society|January 29, 2024
The Impact of Trehalose Dimycolate on the Clinical Course of <i>Mycobacterium avium</i> Complex Pulmonary DiseaseJihoo Lee, Nagatoshi Fujiwara, Joong-Yub Kim, et al.
Pageof 5